BRIEF-Eli Lilly Canada says Health Canada approves Taltz for treatment of moderate-to-severe plaque psoriasis

Tue Jun 21, 2016 12:46pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 21 (Reuters) - Eli Lilly Canada

* Eli Lilly Canada says Health Canada has granted approval for Taltz for treatment of moderate-to-severe plaque psoriasis Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780; )